Sign in

CIK 0001108205

  • Non-accelerated filer
  • Smaller reporting company
Ticker
CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043505116
Phone
+1 617-503-6500
Business address
128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Grant or award Director acquired 185,000 shares (grant or award)
  5. 4 Grant or award Director acquired 185,000 shares (grant or award)
  6. 4 Grant or award Director acquired 185,000 shares (grant or award)
  7. 4 Grant or award Director acquired 185,000 shares (grant or award)
  8. 4 Grant or award Director acquired 185,000 shares (grant or award)
  9. 4 Grant or award Chief Medical Officer acquired 133,750 shares (grant or award)
  10. 4 Grant or award Chief Financial Officer acquired 206,250 shares (grant or award)
  11. 4 Grant or award President & CEO acquired 206,250 shares (grant or award)
  12. 4 Open-market buy Director bought 25,000 shares at $0.98 ($24,500)
  13. 4 Open-market buy President & CEO bought 50,000 shares at $1.06 ($53,000)
  14. 4 Shares withheld for taxes Director gave up 12,193 shares (to pay taxes)
  15. 4 Shares withheld for taxes Director gave up 12,193 shares (to pay taxes)
  16. 4/A Open-market sale Director sold 76,276 shares at an average $2.04 ($155,424)
  17. 4 Open-market sale Director sold 76,276 shares at an average $2.04 ($155,424)
  18. 4 Open-market sale Director sold 116,708 shares at an average $2.38 ($278,037)
  19. 4/A Open-market sale Director sold 110,322 shares at an average $2.59 ($285,682)
  20. 4 Open-market sale Director sold 146,694 shares at an average $2.61 ($383,019)

Page 6 of 24 · 475 filings